Analytical Data
-
Gene name
HPCAL4
- Application
-
Alternative Names
HLP4
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UM19
-
Expression Region
Gly2~Lys191
-
Molecular Weight
24kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HPCAL4, a member of the calmodulin (CaM) superfamily, is a calcium-binding protein that plays a crucial role in various cellular processes, including signal transduction, muscle contraction, and gene expression. The study of recombinant HPCAL4 has gained significant attention due to its diverse biological functions and potential therapeutic applications. Researchers are particularly interested in its structural properties and interaction with other proteins, as understanding these aspects can reveal insights into calcium signaling pathways. The reconstitution of HPCAL4 as a recombinant protein enables scientists to investigate its stability, binding affinities, and functional mechanisms in a controlled environment, thus facilitating the exploration of its role in health and disease. Moreover, due to the implications of calcium dysregulation in various disorders, including neurodegenerative diseases and cardiac dysfunctions, HPCAL4 could serve as a valuable target for drug development and therapeutic intervention. Overall, the recombinant study of HPCAL4 is pivotal in advancing our knowledge of calcium-mediated biological processes and the potential for novel treatments.
